WHO Living Guideline Updated for Drug Treatment of COVID - 19
JAK inhibitor baricitinib strongly recommended for the treatment of severe or critical COVID - 19
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news
More News: COVID-19 | Emergency Medicine | Geriatrics | Internal Medicine | Nurses | Nursing | Pediatrics | Respiratory Medicine